PATENT CLAIM ANALYSIS

Application Number: 15954582
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2020-01
Patent Classification: ["514", "161000"]

Abstract:
This invention reverses male pattern baldness by shocking dormant hair follicles out of their androgen induced hibernation phase back to the active hair-growing anagenic phase. The invention integrates two functions: 1) It blocks synthesis of compounds holding the follicles in the telogenic/hibernating phase and 2) It stimulates synthesis of compounds animating the hair-growing/anagenic phase in the follicular activity cycle. One preferred embodiment comprises an enzyme inhibitor blocking the conversion of testosterone to dihydrotestosterone (DHT), a flavonoid simultaneously increasing synthesis of prostaglandins alternative to prostaglandin D 2 , and a selected cannabinoid compound stimulating restore the hair follicle to its normal growth cycle. This novel trimodal therapy restores the hair follicles to their normal cycling processes and maintains these restorative properties so long as this rebalance in maintained.

Claim (Index 46):
The method of  claim 35  wherein said first formulation is selected from the group consisting of: cannabiesoic acid A (CBEA-A); cannabiesoic acid B (CBEA-B) and cannabieson (CBE).

Metadata:
- Claim Count in Document: 92.0
- Percentile: 91.0
- Lexical Diversity: 1.45745
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13986854', '12074898', '09870424', '11003939', '12803113']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7549465329227099
- 35 USC 102 Novelty (BERT): 0.520045613127751
- Combined Prediction Score: 0.7314564409432139
- Mean Citation Score: 219.449496
- Max Citation Score: 247.36185
- Similarity Product: 142.22992034727932

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test